File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Counterpoint: Should Epidermal Growth Factor Receptor Mutations Be Routinely Tested for in Patients With Lung Cancer? No

TitleCounterpoint: Should Epidermal Growth Factor Receptor Mutations Be Routinely Tested for in Patients With Lung Cancer? No
Authors
Issue Date2013
Citation
Chest, 2013, v. 143 n. 3, p. 600-602 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/186023
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLam, CLDen_US
dc.date.accessioned2013-08-20T11:50:05Z-
dc.date.available2013-08-20T11:50:05Z-
dc.date.issued2013en_US
dc.identifier.citationChest, 2013, v. 143 n. 3, p. 600-602en_US
dc.identifier.urihttp://hdl.handle.net/10722/186023-
dc.languageengen_US
dc.relation.ispartofChesten_US
dc.titleCounterpoint: Should Epidermal Growth Factor Receptor Mutations Be Routinely Tested for in Patients With Lung Cancer? Noen_US
dc.typeArticleen_US
dc.identifier.emailLam, CLD: dcllam@hku.hken_US
dc.identifier.authorityLam, CLD=rp01345en_US
dc.identifier.doi10.1378/chest.12-2548-
dc.identifier.pmid23460150-
dc.identifier.hkuros218574en_US
dc.identifier.volume143en_US
dc.identifier.issue3en_US
dc.identifier.spage600en_US
dc.identifier.epage2en_US
dc.identifier.isiWOS:000317871300007-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats